S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2013-09	Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment Huang, Donghui; Kim, Dong-Wan; Kotsakis, Athanasios; Deng, Shibing; Lira, Paul; Ho, Steffan N.; Lee, Nathan V.; Vizcarra, Pamela; Cao, Joan Q.; Christensen, James G.; Kim, Tae Min; Sun, Jong-mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Mao, Mao Genomics, Vol.102 No.3, pp.157-162	DOI
2016-01	Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer Kim, Ji-Won; Kim, Debora K.; Min, Ahrum; Lee, Kyung-Hun; Nam, Hyun-Jin; Kim, Jee Hyun; Kim, Jin-Soo; Kim, Tae-Yong; Im, Seock-Ah; Park, In Ae Journal of Cancer Research and Clinical Oncology, Vol.142 No.1, pp.157-165	DOI
2019-09	Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations Lee, Yusoo; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Ku, Ja-Lok; Heo, Dae Seog Journal of Thoracic Oncology, Vol.14 No.9, pp.1556-1566	DOI
2023-10	Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Kim, Miso; Kim, Soyeon; Yim, Jeemin; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog Cancer Research and Treatment, Vol.55 No.4, pp.1134-1143	DOI